The Octa Research Team has distanced itself from the comments made by one of its members who said that the AZD1222 Covid-19 vaccine made by British-Swedish drugmaker AstraZeneca would “go to waste” because of its decreased efficacy on the South African variant of the virus.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.